Related Experiment Videos
[Hyperinsulinism probably caused by diffuse pancreatic hyperplasia]
Insights
This case study highlights persistent hypoglycemia in a young boy with hyperinsulinism and psychomotor retardation. Early diagnosis and treatment with diazoxide effectively managed his condition.
Area of Science:
- Pediatric Endocrinology
- Biochemistry
- Medical Imaging
Background:
- Hyperinsulinism is a rare condition causing persistent hypoglycemia.
- Psychomotor retardation can be associated with metabolic disorders.
- Early diagnosis is crucial for managing infant and child metabolic diseases.
Observation:
- A two-year-old boy presented with severe psychomotor retardation and persistent hypoglycemia.
- Biochemical analyses showed high basal insulin levels (RIA > 10 mU/ml) disproportionate to blood glucose.
- Angiography revealed diffuse pancreatic enlargement, suggesting a pancreatic cause.
Findings:
- The patient was diagnosed with hyperinsulinism leading to hypoglycemia.
- Treatment with oral diazoxide normalized and stabilized blood glucose levels.
- This case underscores the link between hyperinsulinism, hypoglycemia, and developmental delays.
Implications:
- Early biochemical and imaging diagnostics are vital for identifying hyperinsulinism.
- Diazoxide is an effective medical treatment for managing hypoglycemia in such cases.
- Prompt intervention can prevent severe neurological complications associated with chronic hypoglycemia.
Abstract:
A case history of a two years seven months old boy with hyperinsulinism and marked psychomotor retardation is presented. In this patient, biochemical analysis revealed persistent hypoglycemia. Basal insulin levels (RIA) were consistently superior to 10 mU/ml. and were higher than would be expected from the child's glycemias. Angiographic study of the celiac trunk revealed diffuse pancreatic enlargement. Therapy was initiated with oral diazoxide normalizing and stabilizing the patient's glycemia. The importance of an early diagnosis of this condition and the necessary biochemical analyses involved are discussed as well as the use of diazoxide in the medical treatment of hypoglycemia.